Morten Herholdt
Stock Analyst at HSBC
(1.24)
# 3,288
Out of 4,814 analysts
17
Total ratings
27.27%
Success rate
-8.37%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Upgrades: Buy | n/a | $217.06 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $148.66 | +51.35% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $118.61 | +188.34% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $104.53 | -33.99% | 2 | Apr 24, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $169 → $170 | $157.44 | +7.98% | 2 | Apr 18, 2024 | |
| BLUE bluebird bio | Maintains: Reduce | $46 → $20 | $4.15 | +391.57% | 2 | Mar 5, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $454.11 | +18.91% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $35.52 | +46.40% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $143.91 | +80.67% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $277.29 | +15.40% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.21 | +862.66% | 1 | Sep 6, 2023 |
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $217.06
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $148.66
Upside: +51.35%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $118.61
Upside: +188.34%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $104.53
Upside: -33.99%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169 → $170
Current: $157.44
Upside: +7.98%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $46 → $20
Current: $4.15
Upside: +391.57%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $454.11
Upside: +18.91%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $35.52
Upside: +46.40%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $143.91
Upside: +80.67%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $277.29
Upside: +15.40%
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.21
Upside: +862.66%